We carried out this meta-analysis to explore the influence of paraoxonase 1 activity on the susceptibility of diabetes mellitus (DM), diabetic macroangiopathy and diabetic microangiopathy. Relevant studies were identified from PubMed, Web of Science and CNKI without language limitation, following the inclusion and exclusion criteria. Statistical analyses were implemented with the STATA 12.0 statistical software. Thirty-six case-control studies were included in the meta-analyses, in which 35 for the association between paraoxonase 1 activity and DM risk, 8 for diabetic macroangiopathy and 7 for diabetic microangiopathy. Paraoxonase 1 activity was significantly associated with the susceptibility of DM in pooled population (SMD = À1.37, 95% CI = À1.79 $ À0.96, P = .000), and Asians (SMD = À2.00, 95% CI = À2.56 $ À1.44, P = .000), but not in non-Asians (SMD = À0.44, 95% CI = À0.91 $ 0.03, P = .069). However, marked heterogeneity was existed (I 2 = 98.10%, P = .000) and subgroup analyses failed to investigate the sources of heterogeneity. Then, meta-regression was performed and found that ethnicity could explain the observed between-study heterogeneity (P = .002). Meanwhile, significant associations were found between paraoxonase 1 activity and diabetic macroangiopathy (SMD = À1.06, 95% CI = À1.63 $ À0.48, P = .000) and diabetic microangiopathy (SMD = À0.72, 95% CI = À1.32 $ À0.13, P = .018). In conclusion, paraoxonase 1 activity plays important roles in the risk of DM, diabetic macroangiopathy and microangiopathy with ethnicity differences. Further studies with large sample and well design are needed to confirm these results.
and development of DM, such as genetic, psychological, lifestyle and environment. Among these influential factors in DM, the serum level, the activity and gene polymorphisms of paraoxonase 1 played important roles in the susceptibility of DM.
Paraoxonase 1, a member of hydrolases with a glycoprotein structure, is a 354 aa glycoprotein of about 45 kD that is synthesized in the liver, released to the blood and binds to the high-density lipoprotein in calcium-dependent manner. 4 Paraoxonase 1 has been demonstrated approximately 200 nucleotide polymorphisms, such as Q192R polymorphism, which was significantly associated with the susceptibility to T2DM by meta-analysis. 5 It has been reported that paraoxonase 1 activity was decreased in heart disease, 6, 7 and a large number of studies have been conducted over the last two decades to demonstrate the relationship of paraoxonase 1 activity and the susceptibility to DM and DM complications. Mackness et al 8 firstly found that paraoxonase 1 activity was significantly higher in diabetic population than non-diabetic population in 1998. While, Kopprasch et al. showed no significant difference in paraoxonase 1 activity between DM and non-DM in different population. [9] [10] [11] [12] [13] [14] Meanwhile, Mackness et al 15 firstly described that paraoxonase 1 activity was significantly higher in DM patients without complications than that with retinopathy in 2000.
Subsequently, there were some studies on the associations between paraoxonase 1 activity and the susceptibilities of DM and DM complications. However, the previously published results remain contentious. Therefore, to firmly demonstrate the association of paraoxonase 1 activity (paraoxon as substrate) with the susceptibility to DM, diabetic macroangiopathy and diabetic microangiopathy, we performed this meta-analysis of data from thirty-six studies.
| METHODS
We carried out literature searches in PubMed, Web of Science and China National Knowledge Internet (CNKI) without language limitation, using the following key words: "PON1" or "paraoxonase 1," "diabetes" or "diabetes mellitus" or "DM" or "T2DM" or "T1DM," and "activity." On the other hand, relevant articles were hand searched to identify additional reports.
| Inclusion and exclusion criteria
The following criteria were used to select articles included in this meta-analysis: (1) published as original case-control studies; (2) paraoxonase 1 activity was detected in serum using paraoxon as the substrate; (3) reported an association between paraoxonase 1 activity and the susceptibilities of DM, diabetic macroangiopathy and/or diabetic F I G U R E 1 Flow diagram of the search strategy and study selection microangiopathy. When the same series of patients were used in more than one article, we used the latest and most complete one. The unit of paraoxonase 1 activity is U/mL.
| Data extraction

| Statistical analysis
Paraoxonase 1 activity in each group was described as mean AE SD.
Standard mean differences (SMD) were used to evaluate the associa- 3 | RESULTS
| Study characteristics
Relevant publications were searched and preliminarily reviewed. As shown in Figure 1 , 564 publications were identified, in which 137
duplicates and 344 irrelevant papers were excluded. Then eightythree citations remaining for further review. Eight original articles lacking of controls, twenty-nine articles used other paraoxonase 1 substrates, two reviews, one performed not in serum, one with paraoxonase 1 gene polymorphism, four with other diseases or protein and one without data of paraoxonase 1 activity were all excluded.
Two studies used the same case series, respectively, so the most recent publication was included. 8, 16 Lastly, 36 case-control studies were included in the meta-analyses. Thirty-four publications were written in English, and two were written in Chinese. 17, 18 The detailed information is shown in Tables 1 and 2 . The first author, published year, country, ethnicity, the types and numbers of cases and controls, and levels of paraoxonase 1 activity for each study were presented.
| Paraoxonase 1 activity and DM risk
As shown in Table 1 or one on NIDDM, 20 and three 12, 32, 34 were unknown. The result showed significant heterogeneity was found (I 2 = 98.10%, P = .000, Figure 2 ). Therefore, we performed subgroup analyses on ethnicity (categorized as Asian and non-Asian groups), type of DM (categorized as T2DM, T1DM and other DMs) and type of control (categorized as healthy control and without DM) to investigate the sources of heterogeneity. However, significant heterogeneities were still existed in each subgroup (data not shown). Therefore, meta-regression was used to identify the sources of this heterogeneity, using the following covariates: published year, sample size, ethnicity, type of control and type of DM. The results showed that ethnicity could explain the observed between-study heterogeneity (P = .002, Table 3 ).
Meta-analysis showed significant relationship between paraoxonase 1 activity and susceptibility of DM (SMD = À1.37, 95% | 4287 CI = À1.79 $ À0.96, P = .000, Figure 2) . Risk of DM obviously increased with low levels of paraoxonase 1 activity. Subgroup analysis on type of DM showed significant relationships found in T2DM subgroup (SMD = À1.54, 95% CI = À2.10 $ À0.98, P = .000), T1DM subgroup (SMD = À0.55, 95% CI = À1.03 $ À0.08, P = .023) and other types of DM (SMD = À1.26, 95% CI = À2.00 to À0.52, P = .001) (Figure 2) . Meanwhile, the result of subgroup analysis on ethnicity showed significant associations between paraoxonase 1 activity and DM in Asian group (SMD = À2.00, 95% CI = À2.56 $ À1.44, P = .000, Supporting information Figure S1 ), but not in non-Asian group (SMD = À0.44, 95% CI = À0.91 $ 0.03, P = .069, Supporting information Figure S1 ). Significant publication bias was found using funnel plot and Egger's test (P = .008, data not shown).
T A B L E 2 Characteristics of studies included in this meta-analysis for the relationship between paraoxon activity and risk of diabetes complications
Author
| Paraoxonase 1 activity and susceptibility of diabetic macroangiopathy
As shown in Table 2 , eight articles focused on the association of paraoxonase 1 activity and the risk of diabetic macroangiopathy, including 737 cases and 671 controls. 17, 18, 22, 30, 31, 34, 35, 44 The results showed that significant heterogeneity was found (I 2 = 94.90%, P = .000, Figure 3A ). Paraoxonase 1 activity was significantly associated with the susceptibility of diabetic macroangiopathy (SMD = À1.06, 95% CI = À1.63 $ À0.48, P = .000, Figure 3A ).
There was no significant publication bias existed, demonstrated by funnel plot and Egger's test (P = .116, data not shown).
| Paraoxonase 1 activity and susceptibility of diabetic microangiopathy
As shown in Table 2 , seven articles focused on the association of paraoxonase 1 activity and the risk of diabetic microangiopathy, including 317 cases and 359 controls. 15, 17, 23, 31, 35, 38, 43 The results showed that significant heterogeneity was found (I 2 = 92.0%, P = .000, Figure 3B ).
Paraoxonase 1 activity was significantly associated with the susceptibility of diabetic microangiopathy (SMD = À0.72, 95% CI = À1.32 $ À0.13, P = .018, Figure 3B ). Meanwhile, there was no significant publication bias, according to funnel plot and Egger's test (P = .533, data not shown).
| DISCUSSION
Our meta-analysis firstly demonstrated the associations between paraoxonase 1 activity and DM, diabetic macroangiopathy and diabetic microangiopathy by polling the individual data set. In the overall meta-analysis of paraoxonase 1 activity, susceptibility of DM significantly increased with low levels of paraoxonase 1 activity, but strong between-study heterogeneity was found. Therefore, to F I G U R E 3 A, Forest plot for the association between paraoxonase 1 activity with diabetic macroangiopathy; B, Forest plot for the association between paraoxonase 1 activity with diabetic microangiopathy address the substantial heterogeneity, subgroup analyses on ethnicity, type of control and type of DM were conducted. But significant heterogeneity was still existed. Then, meta-regression was performed using the following covariates: published year, sample size, ethnicity, type of control and type of DM and the results showed that ethnicity could explain the observed between-study heterogeneity. In addition, subgroup analysis showed significant associations between paraoxonase 1 activity and DM in Asian group, but not in non-Asian group. Paraoxonase 1 activity was different from ethnicity, and significantly higher in Malays and Chinese than Indians. 22 A recent meta-analysis on the associations of paraoxonase 1 Q192R/L55M genetic polymorphisms with susceptibility of T2DM also suggested a significant ethnicity differences. 5 There are huge racial and regional differences in the genetic polymorphisms of paraoxonase 1, according to the 1000 genomes database. 5 Genetic polymorphisms of paraoxonase 1 have been demonstrated to affect the paraoxonase 1 activity. 45 Regarding the paraoxonase 1 Q192R 42 So the effect of interaction between paraoxonase 1 activity and genetic polymorphisms on the susceptibility of DM regarding the ethnic difference needs to be studied in the further.
Diabetic macroangiopathy is one of the most common complications of DM, which reduced the mortality and life quality of DM patients. It is a specific type of accelerated atherosclerosis. In this meta-analysis, paraoxonase 1 activity was significantly associated with the susceptibility of diabetic macroangiopathy. Diabetic microangiopathy including diabetic nephropathy and diabetic retinopathy is also one of the most common complications. Diabetic nephropathy is the leading global cause of end-stage renal disease.
In this meta-analysis, paraoxonase 1 activity was significantly associated with the susceptibility of diabetic microangiopathy. In this meta-analysis, there existed some limitations. First, only articles with English and Chinese language were included in this study, some publication bias may exist. Second, significant heterogeneity was found in our analysis about the association between paraoxonase 1 activity and susceptibility of DM and diabetic complications, and for DM, ethnicity might explain some of the sources of between-study heterogeneity. But there were only 8 and 7 articles included for analysis of the association between paraoxonase 1 activity and diabetic macroangiopathy and microangiopathy, respectively, so we failed to find the sources of heterogeneity. Thus, large sample and welldesigned studies needed to demonstrate the result in the further.
In conclusion, paraoxonase 1 activity plays important roles in the risk of DM, diabetic macroangiopathy and microangiopathy with ethnicity differences. Further studies with large sample and well design are needed to confirm these results.
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